secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K/A
Filed at:   2026-08-21T20:30:15+00:00
Accession:  0001493152-26-039689
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine adds Michael Grissinger to Compensation Committee
----------------------------------------------------------

- Board appointed Michael Grissinger to the Compensation Committee on August 18, 2026.
- Grissinger had joined the Board on August 3, 2026, per prior 8-K.
- He will receive an additional $7,500 per year for committee service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226039689/0001493152-26-039689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226039689/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer